---
created: 2025-04-13
updated: 2025-04-13T10:52
id: q*jvq@{^Zg
specialty: pharmaco
specialty_id: 257
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::06-antiplatelet-drugs
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::03-toxicities-&-side-effects::05-drug-reactions---hematologic
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::08-glycoprotein-iib/iiia-inhibitors
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::glycoprotein-iib/iiia-ihibitors
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::glycoprotein-iib/iiia-inhibitors
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::03-antiplatelet-agents
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
What hematologic adverse effect is associated with GPIIb/IIIa inhibitors (eg, abciximab, eptifibatide, tirofiban)?    **Thrombocytopenia**

---

# Answer
